Share Purchase Plan - Letter to Eligible Shareholders
Released
Released
Announcement PDF
ASX ANNOUNCEMENT
Share Purchase Plan – Letter to Eligible Shareholders
10 October 2024, Melbourne: Elixinol Wellness Ltd (ASX: EXL) ("EXL," "Elixinol," or "the Company")
is pleased to provide an update in relation to its share purchase plan (“SPP”) announced on 3
October 2024.
The Company confirms that letters to eligible shareholder (“SPP Offer Letter”) have been
despatched to eligible shareholders today, being shareholders with a registered address in Australia
or New Zealand on the Company’s register as at 7.00pm (AEST) on Wednesday, 2 October 2024
(“Eligible Shareholders”).
Eligible Shareholders who have provided an email address to the Company’s share registry will be
sent the SPP Offer Letter via an email communication. Eligible Shareholders who have not provided
an email address to the Company’s share registry will receive the SPP Offer Letter via post.
A copy of the SPP Offer Letter has been attached to this release.
The SPP offer opens today, being 10 October 2024, and is expected to close at 5.00pm (AEDT) on
Friday, 25 October 2024 (AEDT).
Authorised for release by Tai Phan, Joint Company Secretary of Elixinol Wellness Limited.
For further information, please contact:
David Fenlon, Non-executive Chair
David.fenlon@elixinolwellness.com
Pauline Gately, Non-executive Director
Pauline.gately@elixinolwellness.com
For more information visit Elixinol Wellness Investor Hub: https://investorhub.elixinolwellness.com
About Elixinol Wellness
Elixinol Wellness Limited (ASX: EXL) is a leader in the global hemp industry, innovating, marketing, and selling
hemp and other plant-derived food, skincare, and nutraceutical products.
In Australia, Elixinol Wellness operates a vertically integrated business which produces, manufactures, and
distributes a range of highly complementary products delivered across four verticals – human nutrition, human
wellness, pet wellness and superfood ingredients. These products are sold under brands including Hemp
Foods Australia, Mt Elephant, Ananda Food, Soul Seed, and Field Day and are sold through grocery, wholesale,
and e-commerce channels. The Australian Superfood Co also supplies Australian natives and superfood
ingredients to white label customers as well as food, beverage, and beauty manufacturers.
Elixinol USA sells high quality Elixinol branded hemp and other plant-derived nutraceutical and skincare
products. www.elixinolwellness.com
Level 4, 100 Albert Road, South Melbourne VIC 3205
info@elixinolwellness.com | www.elixinolwellness.com | @EXLWellness
Disclaimer
Forward looking statements
This document contains certain "forward-looking statements". The words "expect", "anticipate", "estimate",
"intend", "believe", "guidance", "should", "could", "may", "will", "predict", "plan" and other similar expressions
are intended to identify forward-looking statements. Indications of, and guidance on, future earnings and
financial position and performance are also forward-looking statements. Forward-looking statements,
opinions and estimates provided in this document are based on assumptions and contingencies that are
subject to change without notice and involve known and unknown risks and uncertainties and other factors
that are beyond the control of EXL, its directors and management. This includes statements about market and
industry trends, which are based on interpretations of current market conditions.
Forward-looking statements are provided as a general guide only and should not be relied upon as an indication
or guarantee of future performance. Actual results, performance or achievements may differ materially from
those expressed or implied in such statements and any projections and assumptions on which these
statements are based. These statements may assume the success of EXL’s business strategies. The success
of any of those strategies will be realised in the period for which the forward-looking statement may have been
prepared or otherwise. Readers are cautioned not to place undue reliance on forward-looking statements and
except as required by law or regulation, none of EXL, its representatives or advisers assumes any obligation to
update these forward-looking statements. No representation or warranty, express or implied, is made as to the
accuracy, likelihood of achievement or reasonableness of any forecasts, prospects, returns or statements in
relation to future matters contained in this document. The forward-looking statements are based on
information available to EXL as at the date of this document. Except as required by law or regulation (including
the ASX Listing Rules), none of EXL, its representatives or advisers undertakes any obligation to provide any
additional or updated information whether as a result of a change in expectations or assumptions, new
information, future events, or results or otherwise. Indications of, and guidance or outlook on, future earnings
or financial position or performance are also forward-looking statements.
Not an offer in the United States
This document has been prepared for publication in Australia and may not be released to US wire services or
distributed in the United States. This document does not constitute an offer to sell, or a solicitation of an offer
to buy, securities in the United States or in any other jurisdiction in which such an offer would be illegal. Any
securities described in this document have not been, and will not be, registered under the U.S. Securities Act
of 1933, as amended (the “US Securities Act”) or the securities laws of any state or jurisdiction of the United
States. Accordingly, the securities described in this document may not be offered or sold, directly or indirectly,
in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration
requirements of the US Securities Act and applicable securities laws of any state or other jurisdiction of the
United States
Level 4, 100 Albert Road, South Melbourne VIC 3205
info@elixinolwellness.com | www.elixinolwellness.com | @EXLWellness
[EntityRegistrationDetailsLine1Envelope]
[EntityRegistrationDetailsLine2Envelope]
[EntityRegistrationDetailsLine3Envelope]
[EntityRegistrationDetailsLine4Envelope]
[EntityRegistrationDetailsLine5Envelope]
[EntityRegistrationDetailsLine6Envelope]
[EntityRegistrationDetailsLine1Envelope]
[EntityRegistrationDetailsLine2Envelope]
10 October
2024
[EntityRegistrationDetailsLine3Envelope]
[EntityRegistrationDetailsLine4Envelope]
Dear shareholder
[EntityRegistrationDetailsLine5Envelope]
[EntityRegistrationDetailsLine6Envelope]
Important
notice: Notice to Eligible Shareholders of Elixinol Wellness Limited – Share Purchase Plan
On 3 October 2024, Elixinol Wellness Limited (“Elixinol” or “the Company”) announced to ASX Limited (ASX) a Share
Purchase Plan (Offer) to Elixinol shareholders in Australia and New Zealand (Eligible Shareholders) to acquire up to a
value of $30,000 new Elixinol shares (New Shares) at an issue price of $0.0045 per New Share, together with 1 New
Option for every 3 New Shares issued under the SPP. The Record Date for participation is 7:00 pm (Sydney time) on 2
October 2024.
Terms and Conditions in relation to the Offer has been given to ASX and is available to view on the ASX website and
Elixinol’s website at https://investorhub.elixinolwellness.com/announcements. Further details regarding the Offer have
also been announced to the ASX and are available on ASX’s website.
Elixinol will not be printing / dispatching hard copies of the Terms and Conditions or application forms. Instead, an
electronic copy of the Terms and Conditions and your application form is available and accessible by you (using your
Securityholder Reference Number (SRN) or Holder Identification Number (HIN) from your latest Holding Statement, and
your postcode) at the following link: https://investor.automic.com.au.
Shareholders should read the Terms and Conditions in full prior to making an application under the Offer. Your application
under the Offer must be made by making payment in accordance with the personalised payment instructions
1. ONLINE - The Prospectus and
https://investor.automic.com.au/#/home
personalised
Application
Form
can
be
accessed
via:
2. PAPER - Request a paper copy of the Prospectus and the personalised Application Form by contacting the
Company’s Share Registry, Automic on 1300 288 664 (within Australia) or: +61 2 9698 5414 (outside Australia).
to receive communications electronically
You have received this letter by post, as you have not provided your email address or elected to receive all communications electronically. We encourage you to
elect to receive shareholder communications electronically, to update your communication preference scan the QR code to visit https://investor.automic.com.au
To download your application form you have the following 3 choices:
I already have an online account
with the Automic Share registry
I don’t have an online account with
Automic and wish to register for
one
I don’t have an online account with
Automic – but wish to use Automic
for this Offer only
https://investor.automic.com.au
https://investor.automic.com.au/#/sign
up
https://investor.automic.com.au/#/logins
ah
Select: "Existing Users Sign In".
Select Elixinol Wellness Limited from
the dropdown list in the ISSUER field.
Select Elixinol Wellness Limited from
the dropdown list in the ISSUER field.
Once you have successfully signed in,
click on "Documents and Statements". Enter your holder number SRN / HIN
(from your latest Holding Statement).
Download the Prospectus and
Enter a single identifying word from
Application Form. Submit your
your holder name. Enter your
payment using the payment details
Postcode (Australia) or Country of
provided on your personalised
Residence (Outside Australia). Tick
Application form.
box "I am not a robot", then Next
Complete prompts.
Do not return your Application
form.
Once you have successfully signed in,
click on "Documents and Statements".
Download the Prospectus and
Application Form. Submit your
payment using the payment details
provided on your personalised
Application form.
Enter your holder number SRN / HIN
(from your latest Holding Statement).
Enter a single identifying word from
your holder name. Enter your Postcode
(Australia) or Country of Residence
(Outside Australia). Tick box "I am not a
robot", then Next Complete prompts.
Once you have successfully signed in,
click on "Documents and Statements".
Download the Prospectus and
Application Form. Submit your payment
using the payment details provided on
your personalised Application form.
Do not return your Application form.
Do not return your Application
form.
If you are unable to access https://investor.automic.com.au online, you can obtain a copy of the terms and conditions and your
application form – initially by calling Automic Group on 1300 288 664 or emailing corporate.actions@automicgroup.com.au and asking
them to mail a paper copy of the terms and conditions and your application form to you free of charge. After your request has been
acknowledged by Automic you will need to provide your SRN or HIN and postcode to complete this request. To accept an Offer using
these paper copy documents, you will still need to make payment via BPay® or via Electronic Funds Transfer (EFT). For New Zealand
shareholders please follow the instructions on your application form to make payment via Electronic Funds Transfer (EFT).
The Offer closes at 5:00 pm (Sydney time) on 25 October 2024.
Event
Record Date for eligibility to participate in SPP
Date
7.00pm (Sydney time)
Wednesday 2 October 2024
Announcement Date
Thursday 3 October 2024
Prospectus despatched / Opening Date
Thursday 10 October 2024
Issue of Placement Shares and New Options under the Placement
Thursday 10 October 2024
Closing Date
Announcement of results of SPP Offer
Issue of the New Shares and New Options under SPP Offer*
Despatch of holding statements for New Shares and New Options issued under
SPP Offer*
Friday 25 October 2024
Tuesday 29 October 2024
Thursday 21 November 2024
Friday 22 November 2024
Notes:
*Subject to Shareholder Approval (including possible consolidation)
The above dates relate to the SPP Offer, are indicative only and subject to change. All dates and times referenced are
Sydney time. The Company reserves the right, subject to the Corporations Act and the Listing Rules, to extend these
dates without prior notice including extending the last date for receipt of Application Forms, or to delay or withdraw the
Offer at any time without prior notice. If withdrawn, all Application Monies for New Shares which have not been issued will
be refunded (without interest) as soon as practicable.
If you have any query or question about the Offer, please contact tai.phan@vistra.com or for any other registry related
matters please contact Elixinol’s share registrar as follows:
For further information about how to participate in the Offer, please contact Automic.
Email: corporate.actions@automicgroup.com.au
Phone: 1300 288 664 (within Australia), or +61 2 9698 5414 (international) between 8:30 am and 7:00pm (Sydney time)
Monday to Friday.
David Fenlon
Non-Executive Chair
Elixinol Wellness Limited
to receive communications electronically
You have received this letter by post, as you have not provided your email address or elected to receive all communications electronically. We encourage you to
elect to receive shareholder communications electronically, to update your communication preference scan the QR code to visit https://investor.automic.com.au
Share your feedback
Discover